Back to results
US 2010/0143459 A1Published application
Pharmaceutical dosage form for oral administration of tyrosine kinase inhibitor
AssigneeAbbott GmbH & Co. KG
InventorsBernd Liepold, Jörg Rosenberg, Martin Knobloch, Christian Nehen
Life of this patent
Estimating the term…
Abstract
A pharmaceutical dosage form comprises a solid dispersion product of at least one tyrosine kinase inhibitor, at least one pharmaceutically acceptable polymer, and at least one pharmaceutically acceptable solubilizer.
Claims31
A pharmaceutical dosage form which comprises a solid dispersion product of at least one tyrosine kinase inhibitor, at least one pharmaceutically acceptable polymer, and at least one pharmaceutically acceptable solubilizer.
Dependencies are inferred from the claim text.